Drug Resistance, Multiple, Bacterial

"Drug Resistance, Multiple, Bacterial" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

The ability of bacteria to resist or to become tolerant to several structurally and functionally distinct drugs simultaneously. This resistance may be acquired through gene mutation or foreign DNA in transmissible plasmids (R FACTORS).

Descriptor ID	D024901
MeSH Number(s)	G06.099.225.812 G06.225.347.812 G07.690.773.984.269.347.812 G07.690.773.984.300.500
Concept/Terms	Drug Resistance, Multiple, Bacterial Drug Resistance, Multiple, Bacterial Multiple Antibacterial Drug Resistance

Below are MeSH descriptors whose meaning is more general than "Drug Resistance, Multiple, Bacterial".

Biological Sciences [G]
Microbiological Phenomena [G06]
Bacterial Physiological Phenomena [G06.099]
Drug Resistance, Bacterial [G06.099.225]
Drug Resistance, Multiple, Bacterial [G06.099.225.812]
Drug Resistance, Microbial [G06.225]
Drug Resistance, Bacterial [G06.225.347]
Drug Resistance, Multiple, Bacterial [G06.225.347.812]
Physiological Phenomena [G07]
Pharmacological and Toxicological Phenomena [G07.690]
Pharmacological Phenomena [G07.690.773]
Drug Resistance [G07.690.773.984]
Drug Resistance, Microbial [G07.690.773.984.269]
Drug Resistance, Bacterial [G07.690.773.984.269.347]
Drug Resistance, Multiple, Bacterial [G07.690.773.984.269.347.812]
Drug Resistance, Multiple [G07.690.773.984.300]
Drug Resistance, Multiple, Bacterial [G07.690.773.984.300.500]

Below are MeSH descriptors whose meaning is related to "Drug Resistance, Multiple, Bacterial".

Below are MeSH descriptors whose meaning is more specific than "Drug Resistance, Multiple, Bacterial".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Drug Resistance, Multiple, Bacterial" by people in this website by year, and whether "Drug Resistance, Multiple, Bacterial" was a major or minor topic of these publications.

Bar chart showing 14 publications over 7 distinct years, with a maximum of 3 publications in 2007 and 2013

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
2006	2	0	2
2007	1	2	3
2008	2	0	2
2011	0	1	1
2012	0	2	2
2013	1	2	3
2015	0	1	1

Below are the most recent publications written about "Drug Resistance, Multiple, Bacterial" by people in Profiles.

Satlin MJ, Vardhana S, Soave R, Shore TB, Mark TM, Jacobs SE, Walsh TJ, Gergis U. Impact of Prophylactic Levofloxacin on Rates of Bloodstream Infection and Fever in Neutropenic Patients with Multiple Myeloma Undergoing Autologous Hematopoietic Stem Cell Transplantation. Biol Blood Marrow Transplant. 2015 Oct; 21(10):1808-14.

View in: PubMed
Pucci MJ, Bush K. Investigational antimicrobial agents of 2013. Clin Microbiol Rev. 2013 Oct; 26(4):792-821.

View in: PubMed
Hayakawa K, Gattu S, Marchaim D, Bhargava A, Palla M, Alshabani K, Gudur UM, Pulluru H, Bathina P, Sundaragiri PR, Sarkar M, Kakarlapudi H, Ramasamy B, Nanjireddy P, Mohin S, Dasagi M, Datla S, Kuchipudi V, Reddy S, Shahani S, Upputuri V, Marrey S, Gannamani V, Madhanagopal N, Annangi S, Sudha B, Muppavarapu KS, Moshos JA, Lephart PR, Pogue JM, Bush K, Kaye KS. Epidemiology and risk factors for isolation of Escherichia coli producing CTX-M-type extended-spectrum ß-lactamase in a large U.S. Medical Center. Antimicrob Agents Chemother. 2013 Aug; 57(8):4010-8.

View in: PubMed
Fan Z, Senapati D, Khan SA, Singh AK, Hamme A, Yust B, Sardar D, Ray PC. Popcorn-shaped magnetic core-plasmonic shell multifunctional nanoparticles for the targeted magnetic separation and enrichment, label-free SERS imaging, and photothermal destruction of multidrug-resistant bacteria. Chemistry. 2013 Feb 18; 19(8):2839-47.

View in: PubMed
Hom JK, Wang B, Chetty S, Giddy J, Mazibuko M, Allen J, Walensky RP, Losina E, Freedberg KA, Bassett IV. Drug-resistant tuberculosis among HIV-infected patients starting antiretroviral therapy in Durban, South Africa. PLoS One. 2012; 7(8):e43281.

View in: PubMed
Chadwick SG, Hart CE, Mordechai E, Adelson ME, Gygax SE. Staphylococcal Cassette Chromosome mec type and antibiotic susceptibility profiles of vaginal and nonvaginal MRSA clinical isolates. Diagn Microbiol Infect Dis. 2012 Oct; 74(2):210-2.

View in: PubMed
Kim HY, Wiles JA, Wang Q, Pais GC, Lucien E, Hashimoto A, Nelson DM, Thanassi JA, Podos SD, Deshpande M, Pucci MJ, Bradbury BJ. Exploration of the activity of 7-pyrrolidino-8-methoxyisothiazoloquinolones against methicillin-resistant Staphylococcus aureus (MRSA). J Med Chem. 2011 May 12; 54(9):3268-82.

View in: PubMed
Schafer JJ, Goff DA. Establishing the role of tigecycline in an era of antimicrobial resistance. Expert Rev Anti Infect Ther. 2008 Oct; 6(5):557-67.

View in: PubMed
Schafer JJ, Mangino JE. Multidrug-resistant Acinetobacter baumannii osteomyelitis from Iraq. Emerg Infect Dis. 2008 Mar; 14(3):512-4.

View in: PubMed
Schafer JJ, Goff DA, Stevenson KB, Mangino JE. Early experience with tigecycline for ventilator-associated pneumonia and bacteremia caused by multidrug-resistant Acinetobacter baumannii. Pharmacotherapy. 2007 Jul; 27(7):980-7.

View in: PubMed

People

Explore

Similar Concepts

Top Journals

The Thomas Jefferson University web site, its contents and programs, is provided for informational and educational purposes only and is not intended as medical advice nor is it intended to create any physician-patient relationship. Please remember that this information should not substitute for a visit or a consultation with a health care provider. The views or opinions expressed in the resources provided do not necessarily reflect those of Thomas Jefferson University, Thomas Jefferson University Hospital, or the Jefferson Health System or staff.
Please read our Privacy Statement